About Us

About Strategic Medical Associates LLC

Strategic Medical Associates (SMA) seeks to elevate the American population’s knowledge of drugs, biologics, medical devices, and vaccines as well as knowledge of their development processes. It is through these efforts we help improve patient representation in clinical trials that better align with the burden of diseases or conditions the products are designed to treat.

We seek to enhance the understanding, influence, and involvement of trusted health care providers by better informing them of treatment innovations and clinical trials strategies that are relevant to the needs and preferences of their patients. By empowering physicians and their support for multiple roles, we improve community engagement in clinical trials, ensuring that all patient groups are adequately represented, and their diverse health needs are effectively addressed.

Our Team

James H. Powell, MD

Dr. Powell is a graduate and former faculty member (Pharmacology) at Weill Cornell Medical College. He experienced 24 years as a clinical research executive in the biopharmaceutical industry. Powell is a former member of the Secretary’s (HHS) Advisory Committee on Human Research Protections, and PhRMA’s Clinical Trials Committee.

He developed and directed The National Medical Association’s Project IMPACT that included training and education of hundreds of physicians to become clinical trial investigators and thousands of consumers and patients on the clinical trial process.

Brenda Conwell

Brenda, a seasoned clinical trials operations professional, brings 30+ years of experience to the field. Her expertise lies in strategically planning and managing Global Phase I-IV clinical trials across various therapeutic areas.

Throughout her career, she has held leadership positions in clinical operations, demonstrating proficiency in Good Clinical Practices, ethical considerations, and regulatory compliance related to human subject protection. Brenda’s background as a scientist at The Procter & Gamble Company underscores her commitment to advancing clinical research.